Entecavir Hydrate
cas: 209216-23-9 — see every product listed under this CAS number, including other names
Entecavir Hydrate (CAS 209216-23-9) is a chemical reagent available from Chemat. Available pack sizes: 100mg, 25mg, 5mg, 1000mg, 500mg, 2000mg, 5000mg, 10000mg. Offered by: GLPBio, Biosynth.
| brand | GLPBio |
|---|---|
| catalog number | GC16092-100 |
| cas | 209216-23-9 |
| size | 100mg |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| GLPBio | 100mg | 1828.01 Pln | |
| GLPBio | 25mg | 835.75 Pln | |
| GLPBio | 5mg | 531.51 Pln | |
| Biosynth | 1000mg | price on request | |
| Biosynth | 500mg | price on request | |
| Biosynth | 2000mg | price on request | |
| Biosynth | 5000mg | price on request | |
| Biosynth | 10000mg | price on request |
properties
| purity | No data |
|---|---|
| delivery time | To be confirmed by Chemat |
Entecavir hydrate is the monohydrate form of entecavir. A synthetic analogue of 2'-deoxyguanosine, entecavir is a nucleoside reverse transcriptase inhibitor with selective antiviral activity against hepatitis B virus. It is phosphorylated intracellularly to the active triphosphate form, which competes with deoxyguanosine triphosphate, the natural substrate of hepatitis B virus reverse transcriptase, inhibiting every stage of the enzyme's activity, although it has no activity against HIV. Enteclavir is used for the treatment of chronic hepatitis B. It has a role as an antiviral drug and an EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor. It contains an entecavir (anhydrous).
Source: ChEBI
| Molecular formula | C12H17N5O4 |
|---|---|
| Molecular weight | 295.29 g/mol |
| IUPAC name | 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;hydrate |
| InChIKey | YXPVEXCTPGULBZ-WQYNNSOESA-N |
| SMILES | C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N.O |
Computed by PubChem (NCBI)